Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery

NCT03443141 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-02-22

No results posted yet for this study

Summary

A prospective, randomized study will be performed. Patients are randomized using a 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). The primary outcomes variable will be occurrence of incisional SSI. Follow-up will be 30 days postoperatively.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Vitamin E

The applied dressing will be embebbed in Vitamin E

DRUG

Standard dressing

The applied dressing is a normal one without adding any product to it.

Sponsors & Collaborators

  • Hospital General Universitario Elche

    lead OTHER

Principal Investigators

  • Damian Garcia-Olmo, MD, PhD · HOSPITAL REY JUAN CARLOS

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-03-30
Completion
2018-03-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443141 on ClinicalTrials.gov